Mitek Enhances Unassisted Video Verification for Spanish Regulated Entities

MITK
February 13, 2026

Mitek Systems announced on February 12, 2026 that it has strengthened its unassisted video‑verification solution for the Spanish market, adding new capabilities to its SEPBLAC‑compliant digital onboarding platform.

The enhancements improve liveness detection and fraud‑signal analysis, targeting the growing threat of AI‑generated deepfakes, synthetic identities, and screen‑replay attacks that now dominate fraud attempts against onboarding processes. By tightening compliance with Spain’s anti‑money‑laundering and counter‑terrorist‑financing regulations, the update expands Mitek’s footprint in a key market for regulated‑entity onboarding.

Mitek’s Q1 FY2026 results provide context for the announcement: revenue reached $44.2 million, up 19% year‑over‑year, and adjusted EPS rose to $0.26, an 80% increase. The Fraud & Identity segment grew 30% YoY, while Check Verification revenue increased 6% YoY. The company raised its full‑year revenue guidance to $187‑$197 million and adjusted EBITDA margin guidance to 29%‑32%. On February 1, 2026, Mitek retired $155 million of convertible debt, simplifying its balance sheet.

"We delivered a strong start to the fiscal year, with growth across the entire product portfolio and early proof points that our fiscal 2026 Unify and Grow ethos is taking hold," said CEO Ed West, underscoring the company’s confidence in its expanded product suite and financial trajectory.

The new capabilities position Mitek to capture growing demand for secure, frictionless onboarding while maintaining regulatory compliance, reinforcing its strategy to defend against AI‑driven identity fraud and solidifying its leadership in the digital identity verification market.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.